ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2353

TLR2 Activation by Acute Serum Amyloid A Induces Pro-Inflammatory Mechanisms in a Novel Ex Vivo Temporal Artery Explant Culture/Model of Giant Cell Arteritis

Peadar Rooney1, Danielle Molloy1, Jennifer McCormick2, Mary Connolly1, Sinead M. Miggin3, Ashwini Maratha3, Douglas J. Veale4, Conor Murphy5, Eamonn Molloy6 and Ursula Fearon7, 1Rheumatology, Dublin Academic Medical Centre, Dublin, Ireland, 2Dublin Academic Medical Centre, Translational Rheumatology Research Group, Dublin, Ireland, 3Biology, Immune Signalling Laboratory, Maynooth, Ireland, 4Rheumatology, St. Vincent's University Hospital, Dublin 4, Ireland, 5Department of Ophthalmology, Royal Victoria Eye and Ear Hospital, Dublin, Ireland, 6Rheumatology, Dublin Academic Medical Centre, St. Vincent's University Hospital, Dublin, Ireland, 7Rheumatology, Translation Research Group, Dublin Academic Medical Centre, St. Vincent's University Hospital, Dublin, Ireland

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Acute-phase reactants, chemokines, giant cell arteritis, immune response and vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Vasculitis

Session Type: Abstract Submissions (ACR)

Background/Purpose: Giant cell arteritis (GCA) is the most common form of primary vasculitis. The pathogenesis of this disease is characterised by disregulated angiogenesis and inflammatory infiltration, however the causative mechanisms involved in regulating these processes have yet to be elucidated. This study examines the role of acute serum amyloid A (A-SAA), TLR2 activation and the downstream Notch signalling pathway in mediating the pro-inflammatory response in GCA.

Methods: A-SAA expression in Temporal artery (TA) sections from GCA patients was assessed by immunohistology. Ex vivo TA explant cultures were established from GCA patients, and the effect of pro-inflammatory stimuli A-SAA (10μg/ml) and a TLR2 agonist Pam3CYSK4 (1μg/ml) on Ang2, MMP2, MMP9, IL-6 and IL-8 was quantified by ELISA and gelatin zymography. Spontaneous release of A-SAA from ex vivo TA explant cultures was quantified by ELISA. Furthermore, myofibroblast outgrowth from TA explants was assessed using matrigel assays over a time course of 1-15 days. A-SAA induced TA explant and microvascular endothelial cell function in the presence of Notch-1 inhibition (γ-secretase inhibitor (DAPT))  or anti-TLR2 was assessed by gelatine zymography, angiogenic assays and ELISA. The effect of conditioned media from TA explants on Human embryonic kidney (HEK) -TLR2 cells was quantified by NFkb luciferase reporter assays.

Results: A-SAA expression was demonstrated in the advential and intimal regions, particularly localised to endothelial cells. High A-SAA levels (386 +/- 191 pg/ml) were spontaneously released from TA explants cultures. Ex-vivo TA explant cultures spontaneously released pro-inflammatory mediators, maintained cell viability and histological morphology, reflecting the in vivo microenvironment. A-SAA and Pam3CSK4 induced expression of instability growth factor Ang2 (p<0.05), IL-8 (p<0.05), IL-6 (p<0.05) and MMP2 and MMP 9. A-SAA and Pam3CSK4 induced myofibroblast outgrowths from TA explants embedded in matrigel over a time course of 1-15 days. In parallel, Ang2, MMP2/9 and pro-inflammatory chemokine IL-8 were induced in myofibroblast outgrowth cultures in response to A-SAA, and to a lesser extent Pam3CSK4. A-SAA induced Ang2, IL-8, IL-6 were significantly decreased in the presence of Notch inhibitor DAPT.  Furthermore anti-TLR2 inhibited the effects of A-SAA on endothelial cell function.  Finally conditioned media from TA explants significantly induced TLR2 activation through induction of NFκb activation, suggesting the presence of a TLR2 ligand in the inflamed microenvironment.

Conclusion: A-SAA-induced pro-inflammatory events in GAC are mediated through Notch signaling and the TLR2 activation.  A better understanding of A-SAA/TLR2-mediated inflammatory pathways may lead to novel treatment strategies for RA.


Disclosure:

P. Rooney,
None;

D. Molloy,
None;

J. McCormick,
None;

M. Connolly,
None;

S. M. Miggin,
None;

A. Maratha,
None;

D. J. Veale,

Abbott Immunology Pharmaceuticals,

2,

Opsona,

2,

Pfizer Inc,

2,

Roche Pharmaceuticals,

2,

MSD,

2;

C. Murphy,
None;

E. Molloy,
None;

U. Fearon,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/tlr2-activation-by-acute-serum-amyloid-a-induces-pro-inflammatory-mechanisms-in-a-novel-ex-vivo-temporal-artery-explant-culturemodel-of-giant-cell-arteritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology